A randomized, two-arm, phase II trial assessing the efficacy and safety of anthracycline or carboplatin plus docetaxel and tratuzumab as neoadjuvant treatment in HER2-positive breast cancer and prognosis of CTC-MedSci.cn

A randomized, two-arm, phase II trial assessing the efficacy and safety of anthracycline or carboplatin plus docetaxel and tratuzumab as neoadjuvant treatment in HER2-positive breast cancer and prognosis of CTC

Wang, T; Zhou, J; Zhang, S; Xiao, J; Zhang, H; Bian, L; Jiang, Z

BREAST, 2017; 32 ( ): S83

科室
- - 订阅+
  - 更多科室
工具
服务